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Abstract
Embryonic stem cells (ES cells) can differentiate into cells derived from all three germ layers and extraembryonic tissues.
While transcription factors such as, Oct4 and Nanog are well known for their requirements for undifferentiated ES cell
growth, mechanisms of epigenetic repression of germ layer specific differentiation in ES cells are not well understood. Here,
we investigate functions of Mbd3, a component of nucleosome remodeling and histone deacetylation complex (NuRD/Mi-2)
in mouse ES cells. We find that compared to wild type ES cells, Mbd3 knockdown cells show elevated RNA expression of
trophectoderm markers, including Cdx2, Eomesodermin, and Hand1. In parallel, these cells show an increased acetylation
level of histone 3 in promoters of the respective genes, suggesting Mbd3 plays a role in repression of these genes in
undifferentiated ES cells. However, these changes are not sufficient for definitive differentiation to trophectoderm (TE) in
chimeric embryos. When further cultured in ES medium without LIF or in trophoblast stem (TS) cell medium, Mbd3
knockdown cells differentiate into TE cells, which express Cdx2 and, at later stages, trophoblast lineage specific marker
Cadherin 3. These results suggest that Mbd3 helps restrict ES cells from differentiating towards the trophectoderm lineage
and is an important epigenetic player in maintaining full pluripotency of mouse ES cells.
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Introduction
Embryonic stem (ES) cells are derived from the inner cell mass
(ICM) of growing blastocysts. They maintain an undifferentiated
state in defined culture conditions, but can also be induced to
differentiate into diverse cell types representative of all three germ
layers both in vitro and in vivo [1]. ES cells are powerful tools for
expanding our knowledge in mammalian early development and
are thought to hold great promise for regenerative medicine [2].
ES cells share many characteristics of ICM cells at the level of
transcriptional regulation. For example, they both express
pluripotent cell specific transcription factors, such as Oct4 and
Nanog [3–5]. In mouse, loss of Oct4 expression by targeted gene
deletion causes ES cells to develop into trophectoderm [6,7], while
deletion of Nanog causes ES cells to differentiate into primitive
endoderm [5] and to compromise PGC maturation [8].
Considerable efforts have been devoted to elucidate transcriptional
networks of these and other transcription factors and their
associated cofactors [9,10]. These transcription factors have been
implicated in cooperatively activating or repressing a broad range
of downstream target genes [11]. However, less attention has been
paid to epigenetic regulation of these lineage specific transcription
factors. Recent studies have shown that the ES cell pluripotent
state is critically maintained by Polycomb group (PcG) complexes
that mediate suppression of key differentiation genes [12–14].
Other epigenetic studies point to similar lineage restriction
schemes to govern ES cell pluripotency (reviewed in [15]). Despite
these studies, detailed mechanisms of how global epigenetic
control is achieved, especially how lineage specific transcription
programs are suppressed in ES cells, remain to be fully elucidated
(reviewed in [15,16]).
Major epigenetic modifications include DNA methylation,
histone acetylation and methylation which are often closely
coupled [17]. DNA methylation at the dinucleotide CpG in
regulatory regions is a hallmark of stable transcriptional silencing
[18]. Recruitment of specific binding proteins to methylated CpG
islands is believed to repress target gene transcription [19]. On the
other hand, acetylation of histone tails is critical for nucleosome
structure alterations that facilitate DNA accessibility to regulatory
factors [20–22].
Purification of nucleosome remodeling and histone deacetyla-
tion complex (NuRD, also known as Mi-2, NURD, or NRD) links
together two epigenetic modifications: DNA methylation and
histone deacetylation [23–27]. Several components of the NuRD
complex have been shown to be necessary for early embryonic
development. Methylated DNA-linked chromosomal remodeling
and gene silencing are thought to be mediated by methyl-CpG
binding (MBD) proteins [19,28]. Unlike other mammalian MBD
protein, Mbd3 does not bind to methyl-CpG biochemically.
Instead, Mbd3 is directly associated with Chd4 protein as core
PLoS ONE | www.plosone.org 1 November 2009 | Volume 4 | Issue 11 | e7684subunits of the NuRD complex. Study of Mbd3 null mice indicates
that it is essential for early embryogenesis while Mbd2 is
dispensable for viability [29]. Since dynamic epigenetic regulations
occur during ICM formation and differentiation of primary germ
layers, early embryonic lethality caused by Mbd3 deletion may be
attributed to abnormal epigenetic modifications, and therefore
dysregulation of gene expression in early embryos [30,31]. Mbd3
function was reported to be dispensable for ES cell growth in
culture, but essential for their commitment to a full spectrum of
embryonic lineages when aggregated with wild type embryos,
indicating pluripotency of these cells is indeed affected [15,32]. A
detailed mechanism for restricted differentiation of the Mbd3-
deficient cells remains to be elucidated. Interestingly, when
cultured in vitro to promote embryonic stem cell outgrowth,
Mbd3-deficient ICMs fail to generate pluripotent cells [33]. This
difference may be attributed to different sets of molecular factors
that are required for the derivation and maintenance of the
pluripotent state [15,33].
Specification of trophectoderm is the first sign of differentiation
of early mouse embryos. Studies of molecules required for the
specification of the trophectoderm have led to identification of
Oct4 as a negative regulator while Cdx2 as a positive transcription
factor in the process. Conditional deletion of Oct4 in mouse ES
cells leads to trophoblast differentiation and increased expression
of trophoblast-specific markers [6]. Trophoblast stem (TS) cells
can be derived when these cells are cultured under conditions that
promote trophoblast proliferation [34]. On the other hand, Cdx2
is specifically expressed in outer cells of the blastocyst, which are
destined to form trophectoderm [35]. Without functions of Cdx2,
transcription of Oct4 and Nanog are not downregulated in these
outer cells, thus resulting in the implantation failure of the mutant
embryos [35].
Interestingly, though Cdx2 is essential for TS cell self-renewal, it
is dispensable for trophectoderm differentiation induced by Oct4
repression [34]. Since Cdx2 and Oct4 form a complex in early
embryos, reciprocal inhibition of their respective target genes was
proposed to be important in achieving the correct segregation of
the ICM and trophectoderm lineages [34,36].
Although studies using Mbd3
2/2 ES cells have greatly helped us
to understand the roles of NuRD complex in maintaining full ES
pluripotency, the underlying molecular mechanism remains
obscure. In the present study, we selectively reduced expression
of Mbd3 in mouse ES cells by RNA interference to address why
Mbd3 is required for maintain mouse ES cell pluripotency. We find
that reduction of Mbd3 compromises the full differentiation
potential of ES cells. Moreover, with reduced Mbd3 expression,
mouse ES cells are set at an intermediate state and are more prone
to differentiate into trophectoderm. Our results suggest that Mbd3




Mbd3 and its control short hairpin RNA (shRNA) plasmids
were all placed into pSuper.retro.puro vector (Oligo Engine Inc.).
RNA interference (RNAi) target sequences for Mbd3 were selected
using Ambion siRNA converter online software (http://www.
ambion.com/techlib/misc/siRNA_finder.html). The target se-
quences are as follows:
Mbd3 shRNA1: 59-GATGAATAAGAGTCGCCAG-39
Mbd3 shRNA2: 59-AGCCTTCATGGTGACAGAT-39;
Mbd3 control shRNA: 59-GCGAAGTGCATTGTGTGGC-39.
Oligonucleotides were annealed and inserted into Bgl II/
HindIII sites of pSuper.retro.puro vector. EGFP fragment from
pEGFP-N1 (Clontech) was subcloned into the AccI site of the
RNAi plasmids to visualize transfected cells.
Mouse Mbd3 cDNA and full-length human Mbd3 cDNA were
cloned into XbaI and HindIII sites in pRK5-tkneo vector
(Genentech, South San Francisco, Calif. [37]).
Cell culture, plasmid transfection and cell proliferation
assay
Mouse ES cell line CGR8 (kindly provided by Dr. Austin Smith)
[6] was maintained in GMEM (Sigma G5154) supplemented with
10% fetal bovine serum (PAA, pre-tested for ES cells, A15-080),
1 mM sodium pyruvate (Sigma S8636), 2 mM L-glutamine
(Hyclone SH30034), 0.1 mM non-essential amino acids (Hyclone
SH30238), 0.1 mM 2-mercaptoethanol (Sigma M7522), 50 mg/ml
penicillin/streptomycin (Hyclone SV30010), 10
3 Units/ml leuke-
mia inhibitory factor (LIF, Chemicon ESG1107). CGR8 cells were
cultured in plates coated with 0.1% gelatin (Sigma G9391) without
feeder layer cells. NIH3T3 and mouse primary fibroblast cells
were maintained in DMEM (Hyclone SH30022) supplemented
with 10% fetal bovine serum (Hyclone SH30088), 50 mg/ml
penicillin/streptomycin, and 2 mM L-glutamine.
Plasmids were transfected into cells with PolyFect (Qiagen
301105) or Lipofectamin 2000 (Invitrogen 11668) according to the
manufactures’ instructions. All antibiotic selections were started at
24 hours after transfections. Mouse CGR8 ES cells were selected
with 1 mg/ml puromycin (Sigma P8833) and/or 300 mg/ml G418
(Invitrogen 11811-023).
For cell proliferation assays, transfected cells were maintained in
medium without antibiotic selection. Equal numbers of EGFP
positive cells were seeded in triplicate in 12-well plates one day
after transfection. Green fluorescent cells were counted in the
following days. Each experiment was repeated at least three times.
Lentivirus construction, package and infection
For generation of ES cell lines stably overexpressing shRNA, the
oligonucleotides used for Mbd3 shRNA1 were cloned into
pLentilox3.7 vector. For lentivirus production, pLentilox3.7
plasmids were co-transfected with packaging vectors into 293T
cells, and the supernatant was harvested after 48 hours. After
centrifugation and filtration, the supernatant was added into ES
cell suspension for infection. Single colonies were then picked and
propagated.
Western blotting
Cells were collected after trypsinization and washed twice with
cold PBS. Cell lysate was extracted with five times volume of cold
EBC buffer (120 mM NaCl, 50 mM Tris-Cl PH 8.0, 0.5%
Nonidet P-40) containing protease inhibition cocktails (Roche
1697498) and 1 mM PMSF (Amersco 0754). Protocols used
for protein fractionation in SDS-PAGE, blotting and antibody
incubation were essentially the same as those described in
Molecular Cloning [38]. Anti-MBD3 (C-18) (sc-9402) was
purchased from Santa Cruz and anti-a-Tubulin (T5168) antibod-
ies was from Sigma. The protein signals were detected using Pierce
SuperSignal kit (Pierce 34095) and chemiluminescent images were
captured using a cold CCD camera (UVP BioImaging Systems).
Real-time RT-PCR
Total RNAs were extracted with Trizol reagent (Invitrogen
15596-026) followed by DNase I (Roche 11994020) treatment.
Reverse transcription reactions from 2 mg RNA were carried out
Mbd3 and ES Cell Pluripotency
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from 25 ng of RNA were used as templates for quantitative PCR
amplification using SYBR PCR Master Mix (ABI 4367659) in ABI
Prism 7900 HT sequence detection system (Applied Biosystems).
Data were analyzed by SDS2.2 software. Reactions were set up in
triplicate for each sample. Gene expressions were normalized to
b-actin expression. Data are shown as fold inductions relative to
control. Primers are shown in Table S1.
Chromatin immunoprecipitation (ChIP)
About 10
6 cells for ChIP were treated with shRNA for six days
while selected with puromycin for five days. ChIP assays with an
acetylated histone 3 (AcH3) antibody (Upstate, Catalog # 17–245)
were carried out following the manufacture’s protocol. Briefly,
cells were cross-linked with 1% formaldehyde for 10 min at 37uC.
Cell lysates were sonicated at 100 w for 10 s with ultrasonic
apparatus (Scientz JY92-2D). The sonication step was repeated
four times with 30 s intervals. Chromatin extracts containing DNA
fragments with an average size of 500 bp were immunoprecipi-
tated using 5 mg AcH3 antibody. Quantitative PCR was carried
out as described in real-time RT-PCR section. Primers are shown
in Table S2.
Embryoid body (EB) formation and chimeric embryo
production
For EB formation assays, 2610
5 cells were seeded into 35 mm
low attachment sterile cell plate (Ai Si Jin Co., China) in 2 ml ES
cell medium without LIF. Fresh medium was exchanged every two
days.
For chimera production, eight-cell stage embryos were collected
from ICR female mice. Embryos were treated with acidified
Tyrode’s solution (Sigma T1788) for 10 sec. to remove the zona
pellucida. Naked embryos were washed through four droplets of
M2 medium (Sigma M7167) and subsequently cultured in the
‘‘well-in-well’’ of 50 ml KSOM-AA medium (Chemicon MR-106-
D) individually to maintain the developmental competency and
embryonic integration. One small cluster of Mbd3 knockdown
stable cells (10–20 cells) was gently put into the culture droplet
which contained the naked embryo. After 24 h, either aggregated
morula or blastocyst stage embryos were selected. Morula-stage
embryos were further cultured in 50ml droplet of fresh KSOM
medium until the blastocyst stage [39].
Trophoblast stem (TS) cell derivation and cell
immunostaining
CGR8 cells were treated with Mbd3 shRNAs for at least three
days then cultured in TS cell culture condition. TS cells were
derived and maintained in 30% fresh TS medium [GMEM
(Sigma G5154) supplemented with 20% (v/v) of FBS (Hyclone
SH30396), 1 mM sodium pyruvate (Sigma S8636), 2 mM L-
glutamine (Hyclone SH30034), 0.1 mM 2-mercaptoethanol
(Sigma M7522), 50mg/ml penicillin/streptomycin (Hyclone
SV30010), 1mg/ml of sodium heparin (Sigma H3149), and
25 ng/ml of recombinant FGF4 (Sigma F8424)] and 70% (v/v)
of the MEF-conditioned TS medium [40]. MEF-conditioned
medium was collected from mitomycin C-treated MEF cells
cultured in TS medium for 3 days.
For immunostaining, cells were fixed in 4% paraformaldehyde
at room temperature for 10 min. After rinsing twice with PBS,
cells were blocked with blocking buffer (PBS+0.1% Gelatin+1%
BSA+0.02% NaN3+0.4% TritonX-100) for 30 min at room
temperature (for Cdh3 staining, withdrawal of TritonX-100 from
blocking buffer). Primary antibodies anti-Cdh3 (Neomarkers,
MS-1741) and anti-Cdx2 (BioGenex, MU392-UC) were diluted
at 1:100 and 1:50 in blocking buffer, respectively. Secondary
antibody detecting mouse IgG conjugated with TRITC or FITC
(ZhongShanJinQiao, ZF-0313, 0312) were diluted at 1:100 in
blocking buffer. Fixed cells were stained with primary and
secondary antibodies for 1 hour, respectively. Hoechst (Sigma
B2261) were used for cell nuclei staining. Images were captured
with a fluorescence microscope (Nikon Eclipse TE2000-U) or Zeiss
confocal microscope (LSM510META).
Results
Mbd3 is required in mouse ES cells for suppressing
expression of trophectoderm specific genes
Much progress has been made in defining requirements for
maintenance and differentiation of ES cells, but only limited
information is available as to how lineage restriction is achieved
epigenetically [41]. One of the major epigenetic regulations is
modulation of histone acetylation levels at genes required for
certain biological processes. The NuRD complex uniquely
processes both nucleosome remodeling and histone deacetylase
activities and functions primarily in transcriptional repression [42].
To better understand the functions of the NuRD complex in
maintaining pluripotency of mouse ES cells, we investigated its
functional components. We chose to inhibit expression of Chd4
(will be reported elsewhere) and Mbd3 which is essential for very
early development as demonstrated in mouse Mbd3 knock-out
experiments [29]. More recent studies by Kaji and colleagues
strongly suggest that Mbd3 is critically required for mouse
embryonic stem cells both in vitro and in vivo [32,33]. However,
the underlying mechanisms for the requirement remain to be fully
elucidated.
Two RNA interference plasmids were made against mouse
Mbd3. Transfection of either shRNA plasmids can efficiently
reduce both Mbd3 RNA expression and its protein expression in
CGR8 cells (Figure 1A, B). We first asked if Mbd3 shRNAs
treatment influences ES cell proliferation. Mbd3 shRNAs trans-
fected cells (thereafter referred as Mbd3 shRNA cells) showed only
a slightly lower proliferation rate compared with wild type ES cells
(Figure 1C). However, the majority of the Mbd3 shRNA cells
displayed marked differentiated morphology when compared to
control shRNA cells. In contrast to tightly packed ES cell colonies
with smooth edges, Mbd3 shRNA cells showed morphological
changes ranging from a fibroblast-like shape to loosely associated
cell aggregations (Figure 1D, compare a,a9 to b,b9 and c,c9). Minor
cell proliferation changes after Mbd3 shRNA transfection may be
partially explained by ES cell differentiation into other cell types.
These results indicate that Mbd3 may be essential for maintaining
mouse ES cells in an undifferentiated state.
Although mouse ES cells can give rise to all types of cells in an
embryo, they can only differentiate directly into three cell lineages:
trophectoderm, primitive endoderm and primitive ectoderm
(reviewed in [41]). The observed morphological changes after
knockdown of Mbd3 in ES cells did not clearly indicate into which
lineages they may have differentiated. Therefore, we analyzed
specific molecular markers for the three cell lineages in ES cells
after Mbd3 knockdown. Quantitative RT-PCR analysis confirmed
that Mbd3 RNA levels were decreased to about twenty five
percent of controls. Noticeably, the trophectoderm markers Cdx2,
Eomes and Hand1 were upregulated dramatically in Mbd3 shRNA
cells (Figure 2A). Transcription of primitive endoderm markers,
Gata4 and Hnf4 (Figure 2A), Sox7, tPA and AFP (data not shown)
did not show obvious changes. Expression of Gata6, which has
been used as a marker for primitive endoderm, increased at least
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also expressed in early trophectoderm [43]. There were no
meaningful changes at the RNA level of primitive ectoderm
marker Fgf5 and its derivative mesoderm marker T. It appears that
knockdown of Mbd3 promotes ES cells to differentiate towards
trophectoderm based on these molecular studies. The differenti-
ation of ES cells into trophectoderm cells is usually accompanied
by downregulation of pluripotent genes, such as Oct4 and Nanog.
However, we did not observe transcriptional changes for Oct4,
Nanog and Esrrb (Figure 2A), suggesting the observed upregulation
of trophectoderm genes may not be a sufficient indicator of a full
commitment to the trophectoderm lineage.
To test the specificity of the Mbd3 RNA interference effect on
ES cells, we co-transfected human Mbd3 and mouse Mbd3 shRNA
plasmids into ES cells and attempted to rescue the observed
upregulation of trophectoderm markers. Human Mbd3 and
mouse Mbd3 exhibit 95.8% identity at the amino acid level based
on protein alignment. Human Mbd3 cannot be targeted by either
mouse Mbd3 shRNAs as judged by significant DNA sequence
divergence. Quantitative RT-PCR results indicated that human
Mbd3 clearly rescued expression of the trophectoderm markers to
control levels (Figure 2B). To rule out that what we observed was
unique to CGR8 ES cells, we repeated the Mbd3 RNAi
experiment in another mouse ES cell line, R1. Unlike CGR8,
R1 cells are usually maintained on a mouse embryonic fibroblast
feeder layer. Similar to CGR8 cells, expression of trophectoderm
specific genes in R1 cells was increased upon Mbd3 downregula-
tion; however, the morphological changes were less obvious (data
not shown).
Since the NuRD complex is involved in histone deacetylation,
we further examined the histone acetylation status of those genes
that showed upregulation upon Mbd3 knockdown. By scanning
promoter regions of Cdx2, Eomes and Gata6 using chromatin
immunoprecipitation (ChIP) coupled with quantitative PCR
analysis, we uncovered specific regions in these promoters that
show significantly higher acetylated histone 3 modification in
Mbd3 shRNA cells compared with the control (Figure 2C). High
levels of histone 3 acetylation in a promoter are usually correlated
with active gene transcription [44,45]. Thus the ChIP results are
consistent with the upregulated transcription of these genes.
Together, our data suggest that Mbd3 expression is critical to
suppress TE lineage specific gene expression in mouse ES cells.
Suppression of Mbd3 expression is not sufficient for ES
cell differentiation to TE lineage
Since Mbd3 suppression results in ES cell morphological
changes and upregulated trophectoderm associated gene expres-
sion, we next set out to examine whether compromised Mbd3
expression can cause definitive trophectoderm differentiation. We
carried out a chimeric embryo assay in which cells to be tested are
fluorescently labeled and aggregated with early wild type embryos.
By checking distributions of the labeled cells in the chimeras, one
can assign differentiation lineages to the cells [46,47].
Figure 1. Reduced Mbd3 expression in CGR8 cells results in morphological differentiation. A) Quantitative RT-PCR analysis Mbd3 mRNA
expression in Mbd3 shRNA transfected CGR8 cells, which were selected with puromycin for five days. Gene expressions are normalized to internal
control b -actin and presented as the fold induction relative to control shRNA. Error bars represent standard deviation from three technical repeats. B)
Mbd3 shRNA transfections downregulates endogenous Mbd3 protein expression in CGR8 cells detected on western blots. Cells were transfected with
indicated shRNA plasmids. C) Growth curves of CGR8 cells transfected with shRNA plasmids. Only GFP positive cells were counted. Error bars
represent standard deviation. D) CGR8 cells were transfected either with control shRNA(a, a9)o rMbd3 shRNA1/2 (b, b9 and c, c9) and selected for five
days with puromycin. GFP fluorescence in a9,b 9,c 9 indicate that the cells harbor shRNA plasmids. The scale bar represents 50mm.
doi:10.1371/journal.pone.0007684.g001
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chimera development, and thus could make it difficult to interpret
the differentiation potential of labeled Mbd3 shRNA cells. To
circumvent this drawback of transient transfection for in vivo
assays, we made stable Mbd3 knockdown ES cell lines by lentivirus
infection. These cell lines show consistent and stable Mbd3 mRNA
knockdown during the course of the study (Figure 3A), thus
avoiding any significant phenotypic variations possible with
transient cell knockdowns. Among the Mbd3 knockdown stable
lines, the upregulation of Cdx2 is inversely correlated with Mbd3
RNA level. Consistent with the previous transient knockdown
result, the expression level of pluripotency marker Oct4 shows no
obvious change among the stable lines (Figure 3A). We also
observed that these cells showed fibroblast-like morphology with
loose cell-cell contacts (Figure 3B–n, o, p). We aggregated cells
from three independent Mbd3 knockdown stable lines (ESL D8, E8
and G11) and wild type mouse embryos to form chimeras. We
examined which cell lineage the Mbd3 stable cells can associate
with. Mbd3 cells, including those cell lines with obvious
differentiated morphology (ESL G11), were shown to integrate
Figure 2. Suppression of Mbd3 results in the upregulated gene expressions of trophectoderm lineage markers in CGR8 cells. Equal
amounts of DNase-treated total RNA were subjected to quantitative RT-PCR analysis (A, B). A) Cells were transfected with shRNA plasmids and
selected for six days with puromycin. B) Cells were co-transfected with a shRNA plasmid and human Mbd3 or control plasmid and selected with both
puromycin and G418 for five days. The target sequences in Mbd3 shRNA1 and 2 do not exist in human Mbd3 sequence. C) Chromatin
immunoprecipitation (ChIP) analysis using acetylated histone 3 antibody. CGR8 cells were transfected with shRNA plasmids and selected for five days
with puromycin. Various pairs of PCR primer were designed to scan respective promoters. Gene expressions were normalized to internal control b -
actin and presented as the fold induction relative to control samples. Error bars in panel A, B and C represent standard deviation from three technical
repeats.
doi:10.1371/journal.pone.0007684.g002
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At a minimum, this observation suggests that Mbd3 shRNA cells
and ICM cells share similar cell surface molecules essential for cell
sorting. In previous studies [32], Oct4 and Nanog expression
changes little in Mbd3 shRNA cells, which may partially explain
why these cells remain associated with the ICM in the chimera
embryos (Figure 3B). Moreover, we failed to detect Cdx2 protein
expression in these cells (Figure 4b, c), although Cdx2 mRNA levels
were consistently upregulated many fold (Figure 3A), suggesting
that either there is not sufficient mRNA transcription or that
translational regulation plays a role in these cells. Taken together,
these results indicate that reduction of Mbd3 expression is not
sufficient for fully committed TE lineage differentiation.
Mbd3 is required for maintaining full differentiation
potential of ES cells
Although the Mbd3 knockdown ES cells retain the ability to
remain associated with the ICM, whether they retain ES cell like
differentiation capability is not known. Previously, Mbd3
2/2 cells
were shown to retain self-renewal capability upon withdraw of LIF
Figure 3. Knockdown Mbd3 is not sufficient for ES cell differentiation. A) Quantitative RT-PCR analysis of Cdx2 and Oct4 in Mbd3 knockdown
stable lines. Control ESL represents control siRNA stably transfected mouse ES cells; ESL F5, ESL D3 ESL E8, ESL D8, and ESL G11 represent five
independent Mdb3 siRNA stably transfected mouse ES cells. Error bars represent standard deviation from three technical repeats. B) Chimeric analysis
of control and three independent siRNA ES cells in wild type mouse embryos. siRNA stably trasnfected cells were aggregated with wild type mouse
embryos at the eight-cell stage and cultured to the blastocyst stage (a–l). in vitro morphology of the siRNA ES cells used in aggregations (m–p).
Aggregated cells marked by DsRed. Scale bars: l, 200mm (also applies to a to k); p, 100mm (also applies to m, n, o).
doi:10.1371/journal.pone.0007684.g003
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which specific early lineages are compromised is unclear for
Mbd3
2/2 cells.
If Mbd3 shRNA cells show upregulated trophectodermal
markers, an indication of greater potential for re-specification
towards the trophectoderm lineage, we reasoned their capability to
form primitive ectoderm, precursor of three germ layers, might be
compromised. To investigate this possibility, we tried to induce
Mbd3 shRNA-transduced cells to differentiate by adding retinoic
acid (RA, all-trans), an agent which causes wild type ES cells to
convert into cells comprising all three germ layers [48]. Compared
with control shRNA cells, Mbd3 knockdown cells showed reduced
induction of fgf5 (ectoderm) and gata4 (endoderm) (Figure 5A). This
result indicates Mbd3 indeed is required for full differentiation
potential of primitive ectoderm layers.
We also used embryoid body (EB) formation by suspension
culture of ES cells to examine their differentiation capability.
Successfully differentiated EB is a three-dimensional spheroid
structure that mimics post-implantation embryos and contains
three germ layers [49]. Since Mbd3 seems to regulate ES cell
differentiation, it is possible that reduction of Mbd3 expression in
ES cells may also cause abnormal differentiation in EB. We used
three separate Mbd3 knockdown cell lines (ESL D8, E8 and G11)
in the assay. All cell lines except ESL G11 form aggregates by day
five (Figure 5B–e, f, g). By day twelve, in contrast to control cells
which form heterogeneous spheroids in the aggregates, ESL D8
and ESL E8 cells only show aggregated solid ‘‘cell balls’ similar to
those at day five, suggesting the lack of robust differentiation
shown by control ES cells (Figure 5B, i–q). Moreover, even
t h eE S LG 1 1c e l ll i n ew i t ht h emost severe differentiation
morphology failed to generate obvious EB by day five, suggesting
severely compromised differentiation capability (Figure 5B–h).
Before day twelve, the remaining s m a l lE S LG 1 1c e l la g g r e g a t e s
are all disintegrated (data not shown). It is clear that Mbd3 is
required for the formation of normal EB, another indication of
full differentiation potential. Together, these results strongly
suggest that Mbd3 is essential for mouse ES cells to maintain full
pluripotency.
Figure 4. Withdrawal of LIF or cultured under TS cell condition promotes Mbd3 knockdown ES cells to differentiate towards
trophectoderm lineage. Cdx2 staining of control or Mbd3 knockdown stable cells with or without LIF, or cultured under TS culture condition. (a–f)
Cells were cultured in normal ES cell condition with LIF; (g–l) Cells were withdrawal of LIF for 4 days; (m–r) Cells were cultured under TS culture
condition for 6 days. Hoechst stains the cell nuclei. The scale bar represents 50mm.
doi:10.1371/journal.pone.0007684.g004
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trophectoderm lineage
Mbd3 knockdown cells showed substantial increased mRNA
expression of trophectoderm lineage markers, a strong indication
of trophectoderm differentiation. However, we did not detect
Cdx2 protein expression in Mbd3 knockdown cells (Figure 4b, c).
These cells were shown to integrate into the ICM of chimera
embryos (Figure 3) which indicates no definitive differentiation to
trophectoderm lineage at least in the chimeras. Although we can
not rule out that the Mbd3 knockdown cells have reverted to a
more pluripotent state by in vivo factors when placed in the mileu
of a developing embryo, it is also possible that reduction of Mbd3
in ES cells may reduce the intrinsic threshold for these cells to
differentiate towards TE lineage.
Leukemia inhibitory factor (LIF) is one of the key components in
suppression of spontaneous differentiation for mouse ES cells.
Figure 5. Full differentiation potential of mouse of ES cells is compromised when Mbd3 expression is reduced. A) ES cells cultured with
or without retinoic acid for three days were subjected to real-time RT-PCR analysis. For differentiations, 1mM retinoic acid (RA) was used or LIF was
withdrawn from the medium. ES cells were transfected with respective plasmids for three days before RA addition and selected with antibiotics for
five days. Error bars represent standard deviation from three technical repeats. B) Embryoid body (EB) formation of control or Mbd3 knockdown stable
cells. Stable cells (26105) were suspension cultured in ES cell medium without LIF in 35 mm cell dishes. Scale bars: k, 200mm (also applies to a to j); q,
50mm (also applies to l to p).
doi:10.1371/journal.pone.0007684.g005
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differentiate randomly into multiple lineages [50]. However,
mouse ES cells rarely differentiate into trophectoderm in various
culture conditions. Alterations of Cdx2 and Eomes were reported
to trigger trophectoderm differentiation of mouse ES cells [34,51].
We attempted to test whether Mbd3 knockdown cells have a
tendency to differentiate into trophectoderm in the absence of LIF.
After removal of LIF from the culture medium for 4 days, we
detected Cdx2 protein expression in the nuclei of Mbd3 shRNA
cells, but not in the control cells (Figure 4). These results indicate
that Mbd3 knockdown cells seem to be biased to the trophecto-
derm lineage.
Previously, overexpression of Cdx2 in mouse ES cells was
shown to induce trophectoderm differentiation, likely by directly
inhibiting Oct4 functions [34,52]. When ES cells are induced to
differentiate toward trophectoderm, trophoblast stem (TS) cells
can be derived from these cells in appropriate culture conditions
[34,47]. To further confirm that Mbd3 knockdown cells are indeed
biased towards trophectoderm differentiation, we cultured control
and Mbd3 shRNA stable cells under TS culture conditions
containing FGF4 and MEF-conditioned medium [40] for 6 days.
Although we did not observe representative TS colonies, the Cdx2
proteins were detected in Mbd3 shRNA stable cells (Figure 4n, o).
Moreover, with prolonged culture of Mbd3 knockdown cells three
days after shRNAs transfection in TS cell medium, we observed
formation of flattened TS-like colonies by passage two (Figure 6a,
f) which expressed trophectoderm cell surface marker Cadherin3
(Cdh3, also known as placenta Cadherin) (Figure 6d, i). In
contrast, there were no Cadherin3 positive cells in control shRNA
cells under the same culture condition (Figure 6n). It is likely that
both TS culture condition and withdrawal of LIF further promote
Mbd3 shRNA cells towards a trophectoderm lineage. These results
suggest Mbd3 helps mouse ES cells maintain pluripotency by
partial suppression of the trophectoderm lineage.
Discussion
The NuRD complex exists as a co-repressor of gene expression
in a broad range of different cells [23–27; 30–31]. In this study, we
selectively reduced the expression of Mbd3 and further investigated
its epigenetic functions in mouse ES cells. We find that reduction
of Mbd3 expression lowers the threshold of ES cells to differentiate
towards the trophectoderm lineage. Our results thus indicate that
Mbd3 is essential to maintain full mouse ES cell pluripotency
by helping repress the trophectoderm specific differentiation
program.
Trophectoderm specification is the very first cellular differenti-
ation of early mouse embryos. The upregulationof Cdx2 expression
has been shown to be important for the formation of trophectoderm
[35]. In addition, Oct4 is normally downregulated in trophecto-
derm cells in vivo and in vitro. Cdx2 and Oct4 also antagonize each
other at the transcription level [34,35]. However, knockdown of
Mbd3 in mouse ES cells upregulates Cdx2 RNA while Oct4 RNA
remains unchanged (Figure 2A, 3A). Similarly, Oct4 expression was
previously shown to be unchanged in Mbd3
2/2 ES cells [32]. Lack
of Cdx2 expression data in Mbd3
2/2 ES cells precludes direct
comparison of Cdx2 expression in the two studies. Several
observations may be used to explain why Oct4 remains constant
inMbd3compromisedcells.First,Oct4-nullEScellswithconstitutive
expression of transfected Oct4 and overexpression of Cdx2 were
differentiated into TE lineage, suggesting expression of Oct4 alone
is not sufficient for blocking trophectoderm differentiation triggered
by Cdx2 overexpression [34]. Second, Oct4 downregulation during
normal trophectoderm differentiation may require epigenetic
regulations, which may be positively influenced by the NuRD
complex. In fact, Gu and colleagues recently found that Mbd3 was
recruited by GCNF to the Oct4 promoter to repress its expression
through DNA methylation in the process of ES cell differentiation
[53]. Thus loss of Mbd3 in ES cells may lead to deregulation of Oct4
transcription during ES cell differentiation. Furthermore, in the
Mbd3knockdowncells,Cdx2proteinwasnotappreciablyincreased,
indicating that alteration of Mbd3 mRNA level may not significantly
alter Cdx2 translation.
The morphological change and expression of trophectoderm
genes in Mbd3 knockdown cells (Figure 1D, 2, 3A, and 3B m–p)
are considered as early indicators of TE differentiation, but further
chimera analysis (Figure 3B a–l) suggest that these cells have
properties that resemble those of ICM. However, further
Figure 6. Reduction of Mbd3 expression in mouse ES cells promotes trophectoderm stem (TS) cell derivation. Mouse ES cells transfected with
contro or Mbd3 shRNAs for three days were cultured in trophoblast stem cell medium to promote differentiation into TS cells. GFP expression was used to
monitor shRNA plasmids transfection (b, c, g, h, l, and m). Hoechst stains the cell nuclei. Red fluorescence shown on cell boundaries indicates the expression of
cadherin 3, a surface antigen specific to trophoblast cells (d, e, i, j). Scale bars: l, 50mm( a l s oa p p l i e st oa ,b ,f ,g ,k ) ;o ,5 0 mm (also applies to c–e, h–j, m–n).
doi:10.1371/journal.pone.0007684.g006
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such as withdrawal of LIF or TS culture medium resulted in Cdx2
protein expression, indicating that Mbd3 knockdown cells are
biased to differentiation. In contrast, Mbd3
2/2 ES cells could be
maintained in the absence of LIF. The discrepancy between these
two studies appears to be significant, but it should be emphasized
that in both cases disruption of Mbd3 function did not affect cell
proliferation and only affected some differentiation potential. We
showed that in the absence of LIF, Mbd3 shRNA cells express
Cdx2 protein, which might explain why trophoblast markers
Tpbpa and Pl-1 were observed in Mbd3
2/2 ES cells ([32] and
Figure 2A). It would be interesting to test whether Mbd3
2/2 ES
cells are also biased towards TE lineage. It is surprising that Cdx2
protein did not shown increased expression upon MBD3 knock
down despite strong upregulation of its mRNA. It is possible that
translation efficiency of elevated Cdx2 mRNA is negatively
controlled by unknown mechanisms, such as micro RNAs. Future
experiments may help us elucidate the discrepancy between
mRNA and protein expression.
In the embryoid body formation assay, the Mbd3
2/2 ES cells
showed restricted differentiation potential, and this was correlated
with upregulation of trophoblast markers Tpbpa and Pl-1 and
primitive ectoderm marker Fgf5. The embryoid body formation
result using Mbd3 knockdown cells is consistent with that of
Mbd3
2/2 ES cells. Mbd3 shRNA cells are also partially resistant to
retinoic acid induced differentiation towards embryonic ectoderm,
mesoderm and endoderm cells (Figure 4A). We reason that Mbd3
shRNA cells may have undergone necessary, albeit not fully
sufficient, changes towards trophectoderm lineage even though
their morphological changes are obvious. This may also explain
why Mbd3
2/2 ES cells and Mbd3 shRNA cells fail to differentiate
normally upon RA addition or in EB formation ([32], Figure 5).
Therefore, it would be interesting to examine expression of early
trophectoderm markers in Mbd3
2/2 ES cells in addition to
markers of mature trophectoderm. Our results also raise an
interesting point in that morphological change alone, in certain ES
cell lines, cannot be used to judge their differentiation potentials.
The reason why Mbd3 reduction introduces differentiation bias
towards trophectoderm lineage, but not definite commitment is
worthy of further investigation.
Investigation of how the NuRD complex regulates target genes
in ES cells should help elucidate epigenetic mechanisms in
maintaining ES cell pluripotency. Understanding what and how
NuRD complex components are assembled in ES cells and how
they function during lineage specific differentiations will be helpful
in understanding epigenetic controls in general.
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